Chemoinformaics analysis of (+)-trans-Limonene 1,2-epoxide
| Molecular Weight | 152.237 | nRot | 1 |
| Heavy Atom Molecular Weight | 136.109 | nRig | 9 |
| Exact Molecular Weight | 152.12 | nRing | 2 |
| Solubility: LogS | -2.714 | nHRing | 1 |
| Solubility: LogP | 3.119 | No. of Aliphatic Rings | 2 |
| Acid Count | 0 | No. of Aromatic Rings | 0 |
| Base Count | 0 | No. of Aliphatic Carbocycles Rings | 1 |
| Atoms Count | 27 | No. of Aliphatic Hetero Cycles | 1 |
| No. of Heavy Atom | 11 | No. of Aromatic Carbocycles | 0 |
| nHetero | 1 | No. of Aromatic Hetero Cycles | 0 |
| nBridge Head | 0 | No. Saturated Carbocycles | 1 |
| No. of Hydrogen atom | 16 | No. of Saturated Hetero Cycles | 1 |
| No. of Carbon atom | 10 | No. of Saturated Rings | 2 |
| No. of Nitrogen atom | 0 | No. of Arom Atom | 0 |
| No. of Oxygen atom | 1 | No. of Arom Bond | 0 |
| nHA | 1 | APOL | 28.1707 |
| nHD | 0 | BPOL | 17.7873 |
| QED | 0.415 |
| Synth | 3.909 |
| Natural Product Likeliness | 3.61 |
| NR-PPAR-gamma | 0.008 |
| Lipinski | Accepted |
| Pfizer | Rejected |
| GSK | Accepted |
| Golden Triangle | Rejected |
| Pgp-inh | 0.001 |
| Pgp-sub | 0.001 |
| HIA | 0.003 |
| CACO-2 | -4.357 |
| MDCK | 0.0000263 |
| BBB | 0.89 |
| PPB | 0.4674 |
| VDSS | 1.476 |
| FU | 0.485 |
| CYP1A2-inh | 0.103 |
| CYP1A2-sub | 0.608 |
| CYP2c19-inh | 0.038 |
| CYP2c19-sub | 0.907 |
| CYP2c9-inh | 0.027 |
| CYP2c9-sub | 0.211 |
| CYP2d6-inh | 0.008 |
| CYP2d6-sub | 0.863 |
| CYP3a4-inh | 0.113 |
| CYP3a4-sub | 0.35 |
| CL | 15.407 |
| T12 | 0.272 |
| hERG | 0.038 |
| Ames | 0.016 |
| ROA | 0.079 |
| SkinSen | 0.486 |
| Carcinogencity | 0.778 |
| EI | 0.977 |
| Respiratory | 0.963 |
| NR-Aromatase | 0.008 |
| Antiviral | No |
| Prediction | 0.944709 |